Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Magnit bought out 21.5% of shares from foreign investors

9/15/23 MGNT

Phosagro postpones strategy development due to lack of technology

9/15/23 PHOR

Rostelecom-Solar divided its business into commercial and government segments

9/15/23 RTKM

Adobe reported for 9 months of fiscal year 2023

9/15/23 ADBE

Investors will be compensated for income on assets frozen abroad

9/14/23 MOEX

Shareholders of Avangard Bank approved dividends for 6 months 2023

9/14/23 AVAN

Samolet launched a service of renting apartments with subsequent buyout

9/14/23 SMLT

NKHP shipped a record volume of grain for export

9/14/23 NKHP

The Colgate-Palmolive announced a quarterly dividend

9/14/23 CL

Yandex launched a smartphone payment service

9/14/23 YNDX